BlackBarn Capital Partners’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.1M | Sell |
4,625,000
-125,000
| -3% | -$1.41M | 2.98% | 1 |
|
|
2025
Q1 | $47.9M | Buy |
4,750,000
+625,000
| +15% | +$6.31M | 3.05% | 1 |
|
|
2024
Q4 | $48.8M | Buy |
4,125,000
+125,000
| +3% | +$1.48M | 2.68% | 1 |
|
|
2024
Q3 | $46.2M | Buy |
4,000,000
+900,000
| +29% | +$10.4M | 6.07% | 1 |
|
|
2024
Q2 | $32.8M | Buy |
3,100,000
+1,199,406
| +63% | +$12.7M | 2.91% | 1 |
|
|
2024
Q1 | $20M | Buy |
1,900,594
+350,594
| +23% | +$3.7M | 11.32% | 1 |
|
|
2023
Q4 | $17.4M | Buy |
+1,550,000
| New | +$17.4M | 6.29% | 1 |
|